Literature DB >> 23729714

Guillain-Barre syndrome as a paraneoplastic manifestation of disseminated squamous cell carcinoma.

Vishal Navani1, Daniel Webster, Sion K Williams, Daniel Agranoff.   

Abstract

We describe a 65-year-old woman who developed ascending, symmetrical paraesthesia and weakness. This was on a background of metastatic disseminated squamous cell carcinoma, with a likely recurrent mandibular primary. Serum testing for antiganglioside antibodies was strongly positive. Despite a 5-day course of intravenous immunoglobulin, the patient passed away on day 34 of admission. This is the first case, to our knowledge, of Guillain-Barré syndrome in association with squamous cell carcimoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23729714      PMCID: PMC3669847          DOI: 10.1136/bcr-2013-009700

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Guillain-Barré syndrome as first presentation of non-Hodgkin lymphoma.

Authors:  F J Polo-Romero; P Sánchez-Beteta; P Perona-Buendía; A M Pérez-García
Journal:  Neurologia       Date:  2012-01-02       Impact factor: 3.109

2.  Guillain-Barre syndrome in colorectal cancer.

Authors:  Sina Vatandoust; Rohit Joshi; Timothy J Price
Journal:  Asia Pac J Clin Oncol       Date:  2012-03-12       Impact factor: 2.601

Review 3.  Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

Authors:  James J Sejvar; Katrin S Kohl; Jane Gidudu; Anthony Amato; Nandini Bakshi; Roger Baxter; Dale R Burwen; David R Cornblath; Jan Cleerbout; Kathryn M Edwards; Ulrich Heininger; Richard Hughes; Najwa Khuri-Bulos; Rudolf Korinthenberg; Barbara J Law; Ursula Munro; Helena C Maltezou; Patricia Nell; James Oleske; Robert Sparks; Priscilla Velentgas; Patricia Vermeer; Max Wiznitzer
Journal:  Vaccine       Date:  2010-06-18       Impact factor: 3.641

4.  Guillain-Barré syndrome as a paraneoplastic manifestation of small-cell carcinoma of lung.

Authors:  Sajid Naveed; Kelechi Okoli; Jocelyn Hollingsworth; Rahil Kasmani
Journal:  South Med J       Date:  2010-02       Impact factor: 0.954

5.  Pure motor relapsing Guillain-Barré syndrome associated with anti-GM1 antibodies revealing urinary bladder cancer.

Authors:  E Lagrange; O Veran; G Besson
Journal:  Eur J Neurol       Date:  2007-12       Impact factor: 6.089

6.  Guillain-Barré-like syndrome heralding small-cell lung cancer.

Authors:  M Eimil; J Benito-León
Journal:  Eur J Neurol       Date:  2007-11       Impact factor: 6.089

7.  Anti-CTLA-4 antibody-induced Guillain-Barré syndrome in a melanoma patient.

Authors:  S Wilgenhof; B Neyns
Journal:  Ann Oncol       Date:  2011-02-28       Impact factor: 32.976

Review 8.  Intravenous immunoglobulin for Guillain-Barré syndrome.

Authors:  Richard A C Hughes; Anthony V Swan; Pieter A van Doorn
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

Review 9.  Immunotherapy for Guillain-Barré syndrome: a systematic review.

Authors:  Richard A C Hughes; Anthony V Swan; Jean-Claude Raphaël; Djillali Annane; Rinske van Koningsveld; Pieter A van Doorn
Journal:  Brain       Date:  2007-03-02       Impact factor: 13.501

10.  Risk of cancer in patients with Guillain-Barré syndrome (GBS). A population-based study.

Authors:  Maria-Claudia Vigliani; Michela Magistrello; Patrizia Polo; Roberto Mutani; Adriano Chiò
Journal:  J Neurol       Date:  2004-03       Impact factor: 4.849

View more
  1 in total

1.  A Case of Paraneoplastic Guillain-Barré Syndrome Associated with Squamous Cell Carcinoma of the Lung.

Authors:  Danwei Wu; Anne Liu; Esther Baldinger; Alfred T Frontera
Journal:  Cureus       Date:  2018-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.